Followers | 666 |
Posts | 85823 |
Boards Moderated | 0 |
Alias Born | 05/25/2008 |

Thursday, May 25, 2023 12:53:35 PM
What's wrong with death sir? What are we so mortally afraid of? Why can't we treat death with a certain amount of humanity and dignity, and decency, and God forbid, maybe even humor. Death is not the enemy gentlemen. If we're going to fight a disease, let's fight one of the most terrible diseases of all, indifference.
Recent ELEV News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 06:34:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 12:45:11 PM
- Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones • PR Newswire (US) • 01/13/2025 12:30:00 PM
- Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors • PR Newswire (US) • 12/12/2024 12:30:00 PM
- Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 • PR Newswire (US) • 12/05/2024 12:30:00 PM
- Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference • PR Newswire (US) • 11/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 09:15:11 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 12:05:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 12:45:20 PM
- Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 11/06/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 12:00:40 PM
- Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2 • PR Newswire (US) • 09/23/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:15:12 PM
- Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 09/03/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:15:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:45:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:30:28 AM
- Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 08/06/2024 11:10:00 AM
- Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2 • PR Newswire (US) • 08/06/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/15/2024 05:17:58 PM
- Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer • PR Newswire (US) • 06/27/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:28:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:09 PM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM